Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application.... China Pharmaceutical Guidebook Series (3)(4th edition)Access China Management Consulting Ltd.May 1, 2011 139 Pages - SKU: ACCH6328046 |
Additional Information
Report Highlights- An overview of the classification of medicine registration formulated by the SFDA (State Food and Drug Administration in China).
- The material items for application of medicine Registration.
- The requirements of material items for application of medicine registration.
- The requirements of clinical trial for application of medicine registration.
- The significant suggestions for overseas pharmaceutical manufacturers and producers looking to achieve a successful application for their traditional Chinese medicine and natural medicine registration in China.
- Many useful resources of law and regulations, including the Drug Administration Law of the People’s Republic of China, the Regulations for Implementation of the Drug Administration Law of the People’s Republic of China, the Chinese Good Clinical Practice of Pharmaceutical Products, the Chinese Good Manufacturing Practice for Pharmaceutical Products, the Form of Registration Application for Imported Drug, and so on.
- Companies wishing to enter a lucrative drug market in China.
- Companies interested in understanding the latest Chinese regulations on application and approval for imported drug registration.
- Senior executive officers engaging regulatory and registration affairs for drugs.
- Table of Contents
- Preface
- Chapter 1. Introduction
- Chapter 2. Classification of Medicine Registration
- 2.1. Definitions
- 2.2. Classification of Medicine Registration
- Chapter 3. Material Items for Application of Medicine Registration
- 3.1. Comprehensive Materials
- 3.2. Research Materials of Pharmaceutics
- 3.3. Research Materials of Pharmacology and Toxicology
- 3.4. Materials of Clinical Investigation
- Chapter 4. Requirements of Material Items for Application of Medicine Registration
- 4.1. Definitions
- 4.2. The Form of Material Items
- Chapter 5. Requirements of Clinical Trial for Application of Medicine Registration
- 5.1. General Requirements of Clinical Trial
- 5.2. Special Requirements of Clinical Trial for Imported Medicines
- Chapter 6 Conclusion.
- Chapter 7. Appendices
- 7.1. The Drug Administration Law of the People’s Republic of China
- 7.2. The Regulations for Implementation of the Drug Administration Law of the People’s Republic of China
- 7.3. The Good Clinical Practice of Pharmaceutical Products
- 7.4. The Good Manufacturing Practice for Pharmaceutical Products
- 7.5. Form of Registration Application for Imported Drug
- 7.6. References
- 7.7. Resources
- 7.8. Author’s Biography
- 7.9. Company’s Description
More Clinical Trial reports by Access China Management Consulting Ltd.
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (4th edition) by Access China Management Consulting Ltd.
The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and ...
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Chemical Drugs China Pharmaceutical Guidebook Series (2) (4th edition) by Access China Management Consulting Ltd.
See all reports like this >>In China, like in other Western countries, the pharmaceutical authority ----- the SFDA requests applicant to submit complicate and reliable materials for application of drug ...
More China Clinical Trial reports
Marine Freight in China by MarketLine
Introduction Marine Freight in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2006-10, and forecast to 2015). The profile also ...
New Emerging R&D and Clinical Trial Locations by Business Insights
Introduction This report examines and compares the next wave of clinical trial and drug development locations. Over the next 5 to 10 years, the countries identified ...
ChartTrendsĀ®: Nephrology in China 2011 by Decision Resources
ChartTrendsĀ®: Nephrology in China is a syndicated report that captures patient level data from 1000 unique late stage (Stage 3 / Stage 4 / Stage ...
Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (4th edition) by Access China Management Consulting Ltd.
See all reports like this >>The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and ...
More China reports
D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by Dun & Bradstreet Inc.
See all reports like this >>D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
- Business Services & Administration
- International Trade
- Healthcare
- Alternative & Complementary Medicine
- Pharmaceuticals
- General Pharmaceuticals
- Regulation & Policy
- Clinical Trial
Clinical Trial Reports
- Liver Cancer Therapeutics Market to 2018 - Nexavar, the Only Approved Targeted Therapy for Advanced Disease, Continues to Dominate as Other Late Stage Trials Fail
- Astrocytoma Global Clinical Trials Review, H2, 2012
- Thyroid Cancer Global Clinical Trials Review, H2, 2012
- Testicular Cancer Global Clinical Trials Review, H2, 2012
- Rectal Cancer Global Clinical Trials Review, H2, 2012

